커넥티드 약물전달 기기 시장 : 시장 규모, 점유율 및 성장 분석 - 제품 유형별, 기술별, 용도별, 최종 사용자별, 지역별 업계 예측(2026-2033년)

Connected Drug Delivery Devices Market size was valued at USD 7.47 Billion in 2024 and is poised to grow from USD 9.29 Billion in 2025 to USD 52.92 Billion by 2033, growing at a CAGR of 24.3% during the forecast period (2026-2033).

The global connected drug delivery devices market is witnessing notable growth, fueled by the rising adoption of digital health solutions and the demand for personalized healthcare. These devices provide real-time data tracking, along with reminders and notifications for patients, healthcare providers, and caregivers, which facilitates improved medication management and enhances patient outcomes. The incorporation of advanced technologies such as IoT, AI, and cloud computing is transforming the healthcare landscape by boosting patient engagement and enabling remote monitoring. As healthcare systems globally continue to adopt digital transformation strategies and emphasize patient-centric care, the market is well-positioned for significant expansion, reflecting a shift towards more efficient and effective healthcare delivery models.

Top-down and bottom-up approaches were used to estimate and validate the size of the Connected Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Connected Drug Delivery Devices Market Segments Analysis

Global Connected Drug Delivery Devices Market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into connected inhalers, connected injection devices and connected monitoring devices. Based on technology, the market is segmented into bluetooth, wi-fi, near field communication (NFC) and others. Based on application, the market is segmented into diabetes, asthma & COPD, cardiovascular diseases and other. Based on end-user, the market is segmented into hospitals, homecare settings and clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Connected Drug Delivery Devices Market

A significant driver of the connected drug delivery devices market is the growing need for personalized healthcare solutions that are interconnected. These innovative devices provide numerous advantages, including the capability for remote patient monitoring, real-time data collection, and enhanced medication adherence. They empower healthcare providers to effectively track patient health, modify treatment plans, and offer tailored care. The incorporation of connected technology into drug delivery systems bolsters patient engagement and fosters improved treatment outcomes. Furthermore, the rising incidence of chronic illnesses and the demand for sophisticated drug delivery systems play a crucial role in fueling the growth of this market.

Restraints in the Connected Drug Delivery Devices Market

A prominent challenge facing the connected drug delivery devices market is the elevated costs linked to these advanced technologies. The incorporation of features such as wireless connectivity and sophisticated data management systems significantly raises the prices of these devices. This financial barrier hinders widespread adoption, especially in low-resource settings and developing regions, where budget constraints are a critical consideration. Affordability and accessibility issues continue to restrict the uptake of connected drug delivery devices among specific patient demographics and healthcare providers. To foster broader acceptance and stimulate market growth, it will be crucial to address these cost-related obstacles and enhance the affordability of these innovative solutions.

Market Trends of the Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices market is witnessing a significant trend towards the integration of advanced digital technologies, particularly the surge in the use of smart inhalers and other connected devices for respiratory therapies. These innovative solutions, equipped with sensors and wireless connectivity, facilitate comprehensive monitoring of medication adherence, usage patterns, and dosage accuracy. By harnessing mobile applications, patients can receive real-time feedback and personalized insights, enhancing their engagement and empowerment in managing their health. This shift towards data-driven solutions not only improves treatment outcomes but also fosters a more proactive approach to patient care, ultimately driving the market growth for connected drug delivery devices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies
• Startup Analysis

Global Connected Drug Delivery Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Connected Inhalers
  • Metered Dose Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
• Connected Injection Devices
  • Connected Auto-Injectors
  • Connected Pen Injectors
  • Connected Wearable Injectors
• Connected Monitoring Devices
  • Smart Pills
  • Smart Patches

Global Connected Drug Delivery Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Bluetooth
• Wi-Fi
• Near Field Communication (NFC)
• Others

Global Connected Drug Delivery Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diabetes
  • Insulin Delivery
• Asthma & COPD
  • Bronchodilator Delivery
• Cardiovascular Diseases
  • Anticoagulant Delivery
• Other
  • Hormone Replacement Therapy
  • Pain Management

Global Connected Drug Delivery Devices Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
  • Large Hospitals
  • Small And Medium-Sized Hospitals
• Homecare Settings
  • Individual Patients
  • Caregivers
• Clinics
  • Specialty Clinics
  • General Clinics

Global Connected Drug Delivery Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Application, End-User)
  • USA
  • Canada
• Europe (Product Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Findair Sp. z o. o. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIO CORP (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals Industries Ltd (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adherium Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptar Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phillips-Medisize (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• H&T Presspart Manufacturing Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohero Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations